Cargando…
Zika virus oncolytic activity requires CD8(+) T cells and is boosted by immune checkpoint blockade
Glioblastoma multiforme (GBM) is a fatal human cancer in part because GBM stem cells are resistant to therapy and recurrence is inevitable. Previously, we demonstrated Zika virus (ZIKV) targets GBM stem cells and prevents death of mice with gliomas. Here, we evaluated the immunological basis of ZIKV...
Autores principales: | Nair, Sharmila, Mazzoccoli, Luciano, Jash, Arijita, Govero, Jennifer, Bais, Sachendra S., Hu, Tong, Fontes-Garfias, Camila R., Shan, Chao, Okada, Hideho, Shresta, Sujan, Rich, Jeremy N., Shi, Pei-Yong, Diamond, Michael S., Chheda, Milan G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821591/ https://www.ncbi.nlm.nih.gov/pubmed/33232299 http://dx.doi.org/10.1172/jci.insight.144619 |
Ejemplares similares
-
Zika virus has oncolytic activity against glioblastoma stem cells
por: Zhu, Zhe, et al.
Publicado: (2017) -
Development of Zika Virus Vaccines
por: Makhluf, Huda, et al.
Publicado: (2018) -
Correction: Zika virus has oncolytic activity against glioblastoma stem cells
por: Zhu, Zhe, et al.
Publicado: (2017) -
Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development
por: Elong Ngono, Annie, et al.
Publicado: (2019) -
Dengue virus-reactive CD8(+) T cells mediate cross-protection against subsequent Zika virus challenge
por: Wen, Jinsheng, et al.
Publicado: (2017)